By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ErgoMed, Inc. 



San Antonio  Texas    U.S.A.
Phone: 800-333-ERGO Fax: 210-366-1075


SEARCH JOBS


Industry
Biotechnology






Company News
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015 11:23:40 AM
ErgoMed’s Co-Development Partner Ferrer Initiates Phase IIa Study Of Lorediplon In Patients With Insomnia 7/14/2015 9:06:58 AM
ErgoMed Strengthens Management Team & Board 7/2/2015 8:51:06 AM
ErgoMed’s Co-Development Partner AEterna Zentaris (AEZS) Completes Patient Recruitment For Zoptec Phase 3 Study With Zoptarelin Doxorubicin In Advanced Endometrial Cancer 6/30/2015 9:56:46 AM
ErgoMed Selected By Co-Development Partner AEterna Zentaris (AEZS) To Conduct Confirmatory Phase 3 Clinical Trial Of Macrilen In AGHD 6/25/2015 10:06:41 AM
AEterna Zentaris (AEZS) Announces Selection Of ErgoMed To Conduct Confirmatory Phase 3 Clinical Trial Of Macrilen In AGHD 6/25/2015 6:20:20 AM
ErgoMed Acquires Medical Information Service Provider 5/26/2015 9:06:20 AM
ErgoMed’s Co-Development Partner AEterna Zentaris (AEZS) Obtains Positive Recommendation From Data Safety Monitoring Board 4/29/2015 8:53:27 AM
ErgoMed Announces Co-Development Agreement With Dilaforette For Sickle-Cell Disease Treatment 2/19/2015 11:19:17 AM
ErgoMed 2014 Business Update 1/20/2015 9:56:27 AM
123
//-->